You are here: Industry Insights > cancer

News List

Durvalumab improves survival of non-small cell lung cancer patients europeanpharmaceuticalreview
April 18, 2019
Moffitt researchers conducted a Phase III trial which found durvalumab to increase the survival of patients with non-small cell lung cancer…
Cellesce Announces License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Breast Cancer Organoids at Scale b3cnewswire
April 17, 2019
Cellesce Announces License Agreement with Hubrecht Organoid Technology (HUB) for the Expansion of Breast Cancer Organoids at Scale.
FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer drugs
April 17, 2019
FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer.
FDA Approves Balversa (erdafitinib) for the Treatment of Metastatic Bladder Cancer drugs
April 17, 2019
FDA Approves Balversa (erdafitinib) for the Treatment of Metastatic Bladder Cancer.
Rexahn & BioSense Enter License Agreement contractpharma
April 17, 2019
To advance the development and commercialization of RX-3117 for pancreatic cancer and other cancers in Greater China...
Qiagen launches first FGFR-based cancer diagnostic fiercebiotech
April 17, 2019
Alongside Janssen’s accelerated approval of Balversa as the first targeted therapy for metastatic bladder cancer, the FDA also greenlighted Qiagen’s companion diagnostic test to ...
FDA approves first targeted therapy for metastatic bladder cancer worldpharmanews
April 16, 2019
FDA approves first targeted therapy for metastatic bladder cancer.
High-dose vitamin D shows benefit in patients with advanced colorectal cancer worldpharmanews
April 16, 2019
High-dose vitamin D shows benefit in patients with advanced colorectal cancer...
The Classic “Miracle Drug” has “Fallen off the Miracle Path”? Still the “King” in the Cancer Prevention Field PharmaSources/Yefenghong
April 16, 2019
As one of the most commonly used and oldest drugs in the world, aspirin was originally synthesized by Bayer Company in 1897, and marketed two years later.
Pfizer to use Concerto HealthAI technology for cancer treatments pharmaceutical-technology
April 12, 2019
Pfizer has partnered with patient-centred research firm Concerto HealthAI to fast-track actionable patient insights for investigational and commercialised cancer therapies...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page